Biovica: The first European commercial partnership - Redeye

Biovica has secured the initial European launch of DiviTum after signing Toro Medical Group as a commercial partnership agreement for the Netherlands and Polish markets. This is, of course, positive, and we expect some initial sales later in 2023. The proof is in the pudding.

Länk till analysen i sin helhet: https://www.redeye.se/research/891525/biovica-the-first-european-commercial-partnership?utm_source=finwire&utm_medium=RSS